HBP (HBP) News
Follow HBP (HBP) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Helix BioPharma Corp. (HBP) Adds Four Directors; Names New Chair
Helix BioPharma appointed Karen Krumeich, Jamieson Bondarenko, Charmaine Lykins, and Dirk Brockstedt to its board, with Krumeich as Board and Audit Chair; three directors resigned. The board now has six members, four ind
NEWS | Sep 28, 2026, 09:15 PM UTC
L
Helix BioPharma Strengthens Biotech Leadership and Corporate Governance through planned Board Changes
(TheNewswire)Vancouver, British Columbia; September 28, 2026 — TheNewswire — Helix BioPharma Corp. (TSX: “HBP”, OTC PINK: “HBPCF”, FRANKFURT: “HBP0”) (“Helix” or the “Company”), a clinical-stage oncology company developi
NEWS | Sep 28, 2026, 09:15 PM UTC